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Abstract: Astragalus is a very interesting plant genus, well-known for its content of flavonoids,
triterpenes and polysaccharides. Its secondary metabolites are described as biologically active
compounds showing several activities, e.g., immunomodulating, antibacterial, antiviral and
hepatoprotective. This inspired us to analyze the Bulgarian endemic A. aitosensis (Ivanisch.) to
obtain deeper information about its phenolic components. We used extensive chromatographic
separation of A. aitosensis extract to obtain seven phenolic compounds (1–7), which were identified
using combined LC-MS and NMR spectral studies. The 1D and 2D NMR analyses and HR-MS
allowed us to resolve the structures of known compounds 5–7 as isorhamnetin-3-O-robinobioside,
isorhamnetin-3-O-(2,6-di-O-α-rhamno-pyranosyl-β-galactopyranoside), and alangiflavoside,
respectively, and further comparison of these spectral data with available literature helped us with
structural analysis of newly described flavonoid glycosides 1–4. These were described in plant source
for the first time.
Keywords: Astragalus aitosensis; flavonoid; glycoside
1. Introduction
Genus Astragalus comprises from more than 2500 species, which makes it the largest genus in
the family Fabaceae. Astragalus species are cosmopolitans, widely distributed in dry and semi-dry
regions, mainly in the temperate regions of the Northern hemisphere [1]. Certain sources assign genus
Astragalus as the largest genus of flowering plants [2]. About 133 species are distributed in Europe [3],
and 29 have been identified in Bulgaria [4,5]. Fourteen Astragalus species from the Bulgarian flora are
protected by the Bulgarian Biodiversity Act and they are included in the Red List of Bulgaria, as is the
species A. aitosensis, the focus in this investigation [4].
The object of our study—A. aitosensis (Ivanisch.) (syn. Astracantha aitosensis (Ivanisch.) Podlech,
Astracantha arnacantha (M. Bieb.) Podlech subsp. aitosensis (Ivanisch.) Réer & Podlech)—is a Bulgarian
endemic plant and yet it is very scarcely studied for its phytochemical composition [6,7]. A. aitosensis
Molecules 2019, 24, 1419; doi:10.3390/molecules24071419 www.mdpi.com/journal/molecules
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is a low, spiny, tussock-forming shrub with strongly branched stems (30–50 cm in height) [8]. The
plant grows in dry stony places (90–550 m alt) with neutral to alkaline soil. It is distributed only in the
suburbs of the small Bulgarian town Aytos, which gives rise to its name.
From pharmacological point of view, Astragalus species are well-known and widely used as
remedies in the traditional folk medicine of different countries, but only about 100 species from the
genus are researched for their phytochemical composition and properties. Their activity described
in the literature is a result of the presence of flavonoids, saponins, and polysaccharides [9,10], which
endue these plants with immunomodulating, antibacterial, antiviral, hepatoprotective and other
protective pharmacological effects [1,9,10].
Astagalus species show diverse flavonoid composition: flavons, flavonols, flavanons, flavanonols,
chalcones, isoflavons, isoflavans and pterocarpans [1]. Flavonols—in their free and glycosidic
forms—are the most common aglycons, particularly kaempferol, quercetin and methylquercetin
(syn. isorhamnetin). Astragalin, rutoside, hyperoside and isoquercitrin are the most frequently found
glycosidic forms [1,10]. Interesting recent research by Bulgarian scientists reports the presence of a
rarely-met group of flavo-alkaloids [11] and heavily glycosylated tri- and tetra-flavonols [10].
The aim of this study was to isolate content compounds of the methanolic extract from aerial
parts of A. aitosensis and preform their structural elucidation using 1H, 13C, COSY, HSQC, HMBC,
NOESY, and TOCSY NMR experiments. HR-ESI-MS was used for additional confirmation of the
structures revealed by NMR. We report here the isolation and structural elucidation of six isorhamnetin
and one kaempferol glycosides 1−7, four of which are new natural glycosides: three tetra- (1–3) and
one triglycoside (4). The other three already known structures were determined for the first time in
A. aitosensis: with two (5), three (6) and four (7) sugar units, respectively.
2. Results
2.1. Isolation of Compounds
The aerial parts of A. aitosensis were extracted with 80% methanol under reflux. The preliminary
chromatographic analysis showed a bunch of signals of flavonoid compounds, with retention times
predicting a high degree of glycosylation (Figure 1).
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Figure 1. The exemplified overlay of chromatograms of compounds 1–7 at λ 254 nm.
The crude extract was therefore defatted by liquid−liquid partitioning with chloroform and
further fractionated via successive column chromatography with final step of semi-preparative HPLC
purification of the isolated compounds (Figure 2). Their nature (UV spectral properties) and the
behavior of these compounds during separation on reversed phase—the polar character of the
compounds—gave us the idea of flavonoid glycosides with a high glycosylation pattern.
Molecules 2019, 24, 1419 3 of 13
Molecules 2019, 24, x 3 of 15 
 
The crude extract was therefore defatted by liquid−liquid partitioning with chloroform and 
further fractionated via successive column chromatography with final step of semi-preparative 
HPLC purification of the isolated compounds (Figure 2). Their nature (UV spectral properties) and 
the behavior of these compounds during separation on reversed phase—the polar character of the 
compounds—gave us the idea of flavonoid glycosides with a high glycosylation pattern. 
 
Figure 2. Simplified scheme of separation. 
Our separation procedures resulted in isolation of seven pure compounds (1–7) (Figure 3). 
 
Figure 3. Structures of isolated compounds 1–7. 
2.2. Structural Analysis 
To the best of our knowledge, spectral data of four of the isolated compounds (1–4) did not 
correspond to the data of compounds previously published in the literature. The 1D and 2D-NMR 
analysis, HR-MS and comparison with literature allowed us to resolve the structures of compounds 
Figure 2. Simplified scheme of separation.
Our separation procedures resulted in isolation of seven pure compounds (1–7) (Figure 3).
Molecules 2019, 24, x 3 of 15 
 
The crude extract was therefore defatted by liquid−liquid partitioning with chloroform and 
further fractionated via successive column chromatography with final step of semi-preparative 
HPLC purification of the isolated compounds (Figure 2). Their nature (UV spectral properties) and 
the behavior of these compounds during separation on reversed phase—the polar character of the 
compounds—gave us the idea of flavonoid glycosides with a high glycosylation pattern. 
 
Figure 2. Simplified scheme of separation. 
Our separation procedures resulted in isolation of seven pure compounds (1–7) (Figure 3). 
 
Figure 3. Structures of isolated compounds 1–7. 
2.2. Structural Analysis 
To the best of our knowledge, spectral data of four of the isolated compounds (1–4) did not 
correspond to the data of compounds previously published in the literature. The 1D and 2D-NMR 
analysis, HR-MS and comparison with literature allowed us to resolve the structures of compounds 
Figure 3. Structures of isolated compounds 1–7.
. . l l i
t best of our knowledge, spectr l data of four of the isolated compounds (1–4)
did not correspond to the data of comp nds previously published in t literature. The
1D and 2D-NMR analysis, HR-MS and comparison with lit rature allowed us to resolve the
structures of compounds 5–7 as isorhamnetin-3-O-robinobioside [12], isorhamnetin-3-O-(2,6-di-O-α-
rhamno-pyranosyl-β-galactopyranoside) [13,14], and alangiflavoside [15], respectively. The further
comparison of the e spectral data with available literature helped us with structural analysis of newly
described flavonoid glycosides 1–4. For a detailed description, please see Supplementary Materials,
Figures S1–S77.
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The aglycones for compounds 1–6 were determined based on HR-ESI-MS and NMR (1H, 13C,
COSY, HSQC and HMBC) spectral analysis. 1H and 13C spectra are shown in Table 1. HMBC spectra
showed the following significant correlations: proton at C-2′ was a doublet with meta coupling and, in
the HMBC, it showed strong correlation to C-4′ and weak to C-3′. The proton at C-6′ was observed as
doublet of doublet (ortho and meta coupling) and showed strong correlation in the HMBC to C-4′. The
proton at C-5′ was a doublet with ortho coupling, displaying in the HMBC the strong correlation to C-3′
and weak to C-4′. The methoxy group showed correlation to C-3′, and, therefore, the position of the
methoxy is at C-3′ and the aglycone of compounds 1–6 was finally identified as 3′-O-methylquercetin,
syn. isorhamnetin [16].
Table 1. 13C-NMR δC (ppm) (100 MHz); 1H-NMR (600 MHz for 1 and 500 MHz for 2). δH (ppm),
multiplicity (J in Hz).
1 2
δC, Type δH (J in Hz) δC, Type δH (J in Hz)
2 157.8, C 157.2, C
3 133.6, C 133.3, C
4 178.0, C 177.8, C
5 161.3, C 161.6, C
6 99.4, CH 6.45, d (2.02) 98.5, CH 6.19, d (2.00)
7 163.0, C 164.4, C
8 94.4, CH 6.75, d (2.02) 93.4, CH 6.38, d (2.00)
9 156.5, C 157.0, C
10 106.3, C 104.5, C
1′ 121.8, C 121.9, C
2′ 113.3, CH 8.05, m (1.94) 113.7, CH 8.04, d (1.97)
3′ 147.0, C -OCH3 147.0, C -OCH3
4′ 149.4, C -OH 149.2, C -OH
5′ 114.5, CH 6.91, m (8.39) 114.5, CH 6.90, d (8.40)
6′ 122.3, CH 7.62, m (1.92; 8.45) 122.1, CH 7.57, dd (1.90; 8.43)
-OCH3 55.7, CH 4.00 s 55.7, CH3 3.98, s
3-O-gal
1 99.8, CH 5.57, d (7.84) 99.9, CH 5.58, d (7.76)
2 75.1, CH 3.96, dd 74.8, CH 3.97, dd
3 73.9, CH 3.73 dd 73.9, CH 3.74 dd
4 69.0, CH 3.77 dd 69.0, CH 3.77 dd
5 74.1, CH 3.67 dt 74.0, CH 3.64 dt
6 66.0, CH2 3.47/3.68 dd 65.8, CH2 3.47/3.71 dd
Api (1→2)
1 109.2, CH 5.43, d (1.55) 109.1, CH 5.44, d (1.73)
2 76.6, CH 4.01, d 76.9, CH 4.07, d
3 79.5, C -OH 78.8, C -OH
4 74.2, CH2 3.64, d (9.58) 74.3, CH2 3.66, d (n/a)
3.75, d (9.59) 4.07, d (9.70)
5 65.1, CH2 3.64, d (11.45) 61.3, CH2 3.67, d (11.95)
3.75 d (11.56) 3.85 d (11.90)
Rha (1→6)
1 100.5, CH 4.50, d (1.56) 100.5, CH 4.52, d (1.53)
2 70.7, CH 3.51, dd 70.7, CH 3.57, dd
3 70.9, CH 3.46, dd 70.9, CH 3.49, dd
4 72.4, CH 3.25, pt 72.4, CH 3.26, pt
5 68.3, CH 3.49, dq 68.3, CH 3.51, dq
6 16.5, CH3 1.15, d (6.17) 16.5, CH3 1.16, d (6.23)
Glc 7-O-Glc Api (5→1) Glc
1 100.1, CH 5.06, d (7.53) 103.4, CH 4.25, d (7.54)
2 73.3, CH 3.49, dd 73.6, CH 3.17, dd
3 77.0, CH 3.55, dd 76.3, CH 3.21, dd
4 69.9, CH 3.38, dt 70.4, CH 3.27, dd
5 76.4, CH 3.49, dq 76.3, CH 3.27, dt
6 61.1, CH2 3.69/3.94 dd 72.9, CH2 3.68/4.15, dd
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Because of the identification procedure, we describe the elucidation of structures of known
compounds prior to the new compounds. Detailed 1H and 13C chemical shifts for compound 5
are listed in Tables 2 and 3, respectively. The LC-MS analysis showed single peak (tR 7.95 min)
chromatogram with a signal of a deprotonated molecule at m/z [M − H]− 623.16205, which showed
a good correlation with the calculated value of m/z 623.16176 for C28H31O16- (∆ = 0.00029). The
(+)HRMS supported the idea of this molecular formula; the glycosylation pattern was predicted to be
the rhamnose and a hexose from MS/MS analysis of m/z [M + H]+ 625.1175 and observed fragments
m/z [M + H − rhamnose]+ 479.1184, m/z [M + H − rhamnose-oxygen]+ 463.1213, and finally m/z
317.0645 showing the aglycone. The molecular formula C28H32O16 (calcd 624.54408) accorded with the
NMR and further HR-ESI-MS spectral data, and the data of compound 5 corresponded to the reported
data for isorhamnetin-3-O-robinobioside [12].
Table 2. 13C-NMR assignments (100 MHz) for compounds 3–7, δ (ppm).
Compound/Position
3 4 5 6 7
δC, Type δC, Type δC, Type δC, Type δC, Type
2 157.7, C 157.4, C 156.8, C 157.0, C 158.0, C
3 133.3, C 133.8, C 133.5, C 133.0, C 133.4, C
4 177.9, C 178.0, C 177.8, C 177.8, C 177.1, C
5 161.3, C 161.3, C 161.6, C 161.7, C 161.4, C
6 99.3, CH 99.8, CH 99.2, CH 98.4, CH 99.4, CH
7 163.0, C 163.4, C 164.7, C 164.4, C 163.0, C
8 94.4, CH 95.1, CH 94.2, CH 93.3, CH 94.3, CH
9 156.5, C 156.4, C 156.8, C 157.0, C 156.6, C
10 106.3, C 106.1, C 104.4, C 104.5, C 106.2, C
1′ 121.8, C 121.3, C 121.5, C 122.0, C 121.5, C
2′ 113.3, CH 113.9, CH 113.9, CH 113.3, CH 131.0, CH
3′ 147.1, CH 147.5, CH 147.4, C 147.0, C 114.8, CH
4′ 149.3, C 150.1, C 149.9, C 149.1, C 160.1, C
5′ 114.6, CH 115.6, CH 114.6, CH 114.5, CH 114.8, CH
6′ 122.1, CH 122.6, CH 122.4, CH 121.8, CH 131.0, CH
OCH3 56.37, CH3 56.39, CH 56.37, CH 55.79, CH3
3-O-Gal
1 99.3, CH 102.1, CH 102.3, CH 99.4, CH 99.4, CH
2 76.4, CH 74.1, CH 74.0, CH 76.4, CH 76.1, CH
3 74.2, CH 71.6, CH 71.5, CH 74.2, CH 74.3, CH
4 69.2, CH 68.4, CH 68.4, CH 69.1, CH 69.4, CH
5 74.1, CH 73.4, CH 73.4, CH 73.9, CH 74.1, CH
6 65.9, CH2 65.6, CH2 65.6, CH2 65.7, CH2 66.0, CH2
Rha (1→2)
1 101.4, CH 101.3, CH 101.2, CH
2 71.0, CH 71.0, CH 71.0, CH
3 71.0, CH 71.0, CH 70.9, CH
4 72.5, CH 72.5, CH 72.7, CH
5 68.4, CH 68.4, CH 68.4, CH
6 16.0, CH3 16.0, CH3 16.1, CH3
Rha (1→6)
1 100.6, CH 100.5, CH 100.5, CH 100.5, CH 100.5, CH
2 70.7, CH 70.9, CH 70.9, CH 70.7, CH 70.7, CH
3 70.9, CH 71.1, CH 71.1, CH 70.9, CH 70.9, CH
4 72.4, CH 72.2, CH 72.3, CH 72.6, CH 72.5, CH
5 68.3, CH 68.7, CH 68.7, CH 68.3, CH 68.3, CH
6 16.6, CH3 18.3, CH3 18.3, CH3 16.6, CH3 16.6, CH3
7-O-Glc
1 100.1, CH 100.3, CH 100.1, CH
2 73.3, CH 73.6, CH 73.3, CH
3 77.0, CH 76.9, CH 77.0, CH
4 69.9, CH 70.0, CH 69.9, CH
5 76.4, CH 77.7, CH 76.4, CH
6 61.1, CH2 61.2, CH2 61.1, CH2
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Table 3. 1H-NMR assignments (600 MHz) of compounds 3–7 δH (ppm), multiplicity (J in Hz).
3 4 5 6 7





6 6.44, d (2.07) 6.44, d (1.91) 6.19, d (1.97) 6.15, d (1.97) 6.46, d (2.15)
7




2′ 8.09, m (1.93) 8.00, d (1.84) 7.98, d (1.97) 8.07, d (1.94) 8.09, m (8.95)
3′ 6.90, m (8.90)
4′
5′ 6.91, m (8.44) 6.90, d (8.39) 6.88, d (8.44) 6.90, d (8.42) 6.90, m (8.90)






8.43) 8.09, m (8.95)
OCH3 3.83, s 3.84, s 3.83, s 4.00, s -
3-O-Gal
1 5.79, d (7.84) 5.47, d (7.73) 5.45, d (7.67) 5.59, d (7.83) 5.59, d (7.74)
2 3.97, dd 3.60, dd 3.57, dd 3.96, dd 3.95, dd
3 3.78, dd 3.57, dd 3.57, dd 3.76, dd 3.70, dd
4 3.80, dd 3.62, dd 3.63, dd 3.81, dd 3.75, dd
5 3.74, dt 3.42, dt 3.41, dt 3.71, dt 3.64, dt
6 3.54/3.73dd 3.30/3.60 dd 3.31/3.61 dd 3.52/3.72 dd 3.46/3.69 dd
Rha (1→2)
1 5.16, d (1.52) 5.16, d (1.53) 5.21, d (1.32)
2 4.00, dd 4.00, dd 4.00, dd
3 3.75, dd 3.76, dd 3.78, dd
4 3.33, pt 3.32, pt 3.33, pt
5 4.04, dq 4.03, dq 4.06, dq
6 0.89, d (6.25) 0.89, d (6.23) 0.98, d (6.23)
Rha (1→6)
1 4.53, d (1.53) 4.41, d (1.53) 4.41, d (1.53) 4.55, d (1.55) 4.49, d (1.24)
2 3.54, dd 3.37, dd 3.38, dd 3.59, dd 3.48, dd
3 3.49, dd 3.28, dd 3.28, dd 3.51, dd 3.46, dd
4 3.25, pt 3.06, pt 3.07, pt 3.26, pt 3.25, pt
5 3.52, dq 3.36, dq 3.34, dq 3.54, dq 3.49, dq
6 1.16, d (6.08) 1.04, d (6.18) 1.03, d (6.25) 1.17, d (6.22) 1.16, d (6.21)
7-O-Glc
1 5.06, d (7.24) 5.05, d (7.89) 5.07, d (7.45)
2 3.48, dd 3.24, dd 3.48, dd
3 3.53, dd 3.27, dd 3.53, dd
4 3.39, dd 3.15, dd 3.38, dd
5 3.50, dt 3.43, dt 3.49, dt
6 3.69/3.92, dd 3.44/3.68, dd 3.69/3.91, dd
ESI– HRAM spectrum of compound 6 showed presence of signal of deprotonated molecule
m/z [M − H]− 769.21948 (calcd for C34H41O20- 769.219667 m/z; ∆ = 0.00019). The MS/MS analysis
(a minimal fragmentation using 20 eV) in a positive mode showed the presence of a protonated
parental ion m/z [M + H]+ 787.2284 and fragments corresponding to loss of two rhamnose units and
a hexose m/z 641.1708, 479.1180 and 317.0653. The molecular formula C34H42O20 (Mr 770.68528)
is in accordance with the NMR and HR-ESI-MS spectral data and 1H and 13C chemical shifts for
compound 6 are listed in Tables 2 and 3, respectively. Compound 6 was therefore identified as
isorhamnetin-3-O-(2,6-di-O-α-rhamno-pyranosyl-β-galactopyranoside) [13,14].
The molecular formula C39H50O24 (Mr 902.7999) is in accordance with the NMR and HR-ESI-MS
spectral data, where the mass of deprotonated molecule was found at m/z [M − H]− 901.2624 (calcd
901.2619; ∆ = 0.0005). The detailed MS analysis of fragments observed in spectrum showed signal
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m/z [M + H]+ 903.2759, m/z [M + H − rhamnose]+ 757.2178, m/z [M + H − rhamnose − rhamnose]+
611.1601, m/z [M + H − rhamnose − rhamnose − hexose]+ 449.1078, and aglycone m/z 287.0549, with
pairs of fragments showing loos of water 18 m/z [M + H − rhamnose − H2O]+ 741.2245, m/z [M +
H − rhamnose − rhamnose − H2O]+ 595.1660. The spectrum also showed fragments of sugars m/z
309.1186 (hexose-rhamnose). 1H and 13C chemical shifts for compound 7 are listed in Tables 2 and 3
respectively. NMR data of compound 7 and mass spectral analysis results show a good accordance
with the data already reported for alangiflavoside [15].
Based on the previously described analysis of known compounds, we tried to identify the other
isolated compounds, which showed differences from those previously described in the literature.
Some of the fragmentation MS/MS results used for the identification of compounds 1–4 are depicted
in Figure 4.
Compound 1 was isolated as a yellow amorphous powder. The UV spectra analysis showed a
typical flavonoid course, with the retention time typical for glycosylated substances. The HR-ESI-MS
in a negative mode displayed a molecular ion m/z [M − H]− 917.2572 (calc. for [M − H]− 917.256841),
confirming the molecular formula C39H50O25 with calculated molecular mass 918.7993 Da. HRESIMS
showed an adduct formation m/z [M + HCOO]− 963.26269 (confirming the analyte), and a hexose (m/z
162.0235) loss leading to m/z 755.21208 (possible representing cleavage of glucose from 7-O position or
galactose from 3-O- position of expected flavonol skeleton). Furthermore, the MS in a positive mode
confirmed this loss showing precursor ion m/z [M + H]+ 919.2705 with product ions formed either
by subsequent loses of a pentose (m/z 787.2264), a rhamnose (m/z 625.1750), and a hexose (479.1170)
unit, or loss of rhamnose (m/z 773.2136) followed by hexose (m/z 611.1613) moieties (see Figure 4).
After lining up interpretation of NMR spectra (Table 1) with MS analysis, the structure of compound 1
was elucidated to be the isorhamnetin substituted by four sugars. One of them is a 6-deoxyhexose
(a methyl group as doublet), two are hexoses (a glucose, a galactose), and one is a pentose. DEPT
spectrum of compound 1 showed four methylene groups. Altogether, two of them belong to each
hexose (the glucose and galactose), respectively, and since a 6-deoxyhesose (expected rhamnose) does
not have a methylene moiety, the two left CH2 moieties must belong to a pentose. Four anomeric
protons are found in HMBC spectrum: δH 5.57 ppm, (1H, d, J = 7.84 Hz), δH 5.43 ppm (1H, d, J = 1.55
Hz), δH 4.50 ppm (1H, d, J = 1.56 Hz) and δH 5.06 ppm (1H, d, J = 7.53 Hz), corresponding to carbon
atoms with δC 99.8 ppm, δC 109.2 ppm, δC 100.5 ppm and δC 100.1 ppm from the HSQC spectrum.
After complete resonance assignments, analyses of coupling constants, intensities, interpretation
of cross-peaks in the COSY spectrum, and 13C-NMR chemical shift values, one hexose moiety was
identified as a β-glucosyl unit, the second as a β-galactosyl moiety, the 6-deoxysugar was identified
to be the α-rhamnose, and the pentose was recognized as the β-apiose, which contains two of the
above-mentioned methylene groups. 13C values of C-6 indicate that β-glucose residue is not connected
to other sugar unit (δC 61.1 ppm), while the β-galactose moiety is connected at C-6 position (δC 66.0
ppm—shifted to a higher field). HMBC correlations allowed us to elucidate the precise structure of
the sugar chains and the positions of their attachment to the aglycone. The anomeric proton (δH
5.06 ppm) of the β-glucose moiety showed a three-bond correlation to C-7 (δC 163.0 ppm) of the
aglycone, while a HMBC correlation between the anomeric proton of the galactose (δH 5.57 ppm)
and the carbon at δC 133.6 ppm indicated that the galactosyl unit is connected at C-3 towards the
aglycone. The anomeric proton of α-rhamnose correlated to C-6 in the β-galactose (δC 66.0 ppm). The
anomeric atom of the last pentose sugar (apiose) δH 5.43 ppm bonded to δC 109.2 ppm showed a
HMBC correlation with C-2 of the β-galactose molecule (δC 75.1 ppm). The remaining two methylene
groups (δC 74.2 ppm and δC 65.1 ppm) were recognized as carbons C-4 and C-5 in the apiosyl moiety.
Hence, according to all interpreted spectra, we identified compound 1 as a new natural product named
isorhamnetin-3-O-[β-D-apiofuranosyl-(1→2)-[α-L-rhamnopyranosyl-(1→6)]-β-D-galactopyranosyl]-7-
O-β-D-glucopyranoside.
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Compound 2 was obtained as a yellow amorphous powder. The spectral analysis showed data
very similar to those observed for compound 1 (Table 1), and the only difference found was the
presence of a β-glucosyl residue connected to the sugar chain, attached to the 3-O position (particularly
C-5 of apiosyl residue); a connection to the 7-O position of the aglycone was not found. Further
interpretation of HRESIMS supported this suggestion by observing a lacking of the fragment of a
hexose loss (m/z 162.0235), which can be observed in spectra of all compounds possessing glucose
attached at 7-O position (compounds 1, 3, 4 and 7). The HR-ESI-MS in negative mode displayed
a molecular ion m/z [M − H]− 917.25696 (calculated for m/z [M − H]− 917.256841), confirming
molecular formula C39H50O25 with calculated molecular mass 918.7993 Da. Adduct formation [M
+ HCOO]− (m/z 953.2336) and [M + Cl]− (m/z 963.2621) was observed in a negative ESI mode.
Furthermore, MS in a positive mode confirmed this by [M + H]+ with m/z 919.2709, and a series
of corresponding losses of four sugar units at a minimal fragmentation of 20 eV: m/z 773.2136 as
loss of rhamnosyl unit, m/z 625.1759 loss of rhamnose and hexose, and 479.1185 corresponding to
isorhamnetin hexoside after loss of three sugar units of rhamnose, hexose and pentose. In addition,
the aglycone signal m/z 317.0655 and the fragment ion m/z 603.2144, interpreted as the chain of all
sugar moieties with corresponding fragments m/z 441.1610 and m/z 457.1552 after losses of terminal
hexose and rhamnose, respectively, were detected. According to differences in chemical shifts in NMR
spectral data (compared with 1), the glucosyl moiety changed its bonding position from 7-O position
of the aglycone to C-5 position of the β-apiosyl residue (see Table 3). The compound was therefore
identified as isorhamnetin-3-O-[β-D-glucopyranosyl-(1→5)-β-D-apiofuranosyl]-(1→2)-robinobioside
or [α-L-rhamnopyranosyl-(1→6)]-β-D-galactopyranosyl], a newly described flavonoid glycoside.
Compound 3 was isolated as a yellow amorphous powder. Rt of compound 3 was 4.61 min, again
slightly different from other isolates. The HR-ESI-MS in a negative mode displayed a molecular ion
m/z [M − H]− 931.27352 (calcd [M − H]− 931.272491), confirming molecular formula C40H52O25
with calculated molecular mass 932.82588 Da. HRESIMS showed additional adduct formation at m/z
[M + HCOO]− 977.27862, and a hexose loss (m/z 162.05387) leading to m/z 769.21965 (representing
supposed cleavage of glucose from 7-O position). In the HRAM ESI positive mode, [M + H]+ ion with
m/z 933.2810 (calcd [M + H]+ 933.2876) was obtained. Fragmentation with collision energy of 20 eV
gave ions with m/z 787.2229 and m/z 771.2324 formed by loss of hexose and rhamnose, respectively.
Further subsequent loses of the hexosyl and rhamnosyl moieties resulted fragments with m/z 625.1679
(aglycone-rhamnosyl-hexoside) and m/z 641.1652 (aglycone-hexosyl-hexoside). Finally, ions of m/z
479.1082 (hexosylated aglycone) and aglycone m/z 317.0526 (supposed isorhamnetin) were found.
Together with an interpretation of NMR spectra (Tables 2 and 3), the structure was predicted to be
composed of isorhamentin and four sugar moieties. Two of them were recognized as 6-deoxyhexoses
(two methyl groups in the form of the doublet), and the other two were hexoses (possibly a glucose, or
a galactose). DEPT spectrum showed their two methylene groups (δC 61.1 ppm and 65.9 ppm) that
belonged to the galactose and the glucose, respectively. We observed four anomeric protons in HSQC
spectrum: δH 5.79 ppm, (1H, d, J = 7.84 Hz), δH 5.16 ppm (1H, d, J = 1.52 Hz), δH 4.53 ppm (1H, d,
J = 1.53 Hz) and δH 5.06 ppm (1H, d, J = 7.24 Hz), corresponding to carbon atoms δC 99.3 ppm, 101.4
ppm, 100.6 ppm and 100.1 ppm, respectively. After complete resonance assignments and analyses of
coupling constants, intensities of cross-peaks in the COSY spectrum, and 13C-NMR chemical shift
values, one hexose moiety was identified as a β-glucosyl unit, the other as a β-galactosyl moiety, and
the 6-deoxy sugars were found to be α-rhamnosyl moieties. 13C values indicated that β-glucosyl
residue is free at C-6 (δC 61.1 ppm), while the β-galactose is bonded to C-6 (δC 65.9 ppm—shifted to
a higher field). According to HMBC correlations, structure of the side chains and their attachment
to the aglycone were established. Anomeric proton (δH 5.06 ppm) of the glucose moiety showed a
three-bond correlation to C-7 (δC 163.0 ppm) of the aglycone, while an HMBC correlation between the
anomeric proton of the β-galactosyl moiety (δH 5.79 ppm) and the carbon at δC 133.3 ppm indicated
that the β-galactosyl unit is bonded at C-3 toward the aglycone. The anomeric proton of one of the
α-rhamnose residues (δH 5.16 ppm) was correlated to position C-2 of the β-galactose (δC 76.4 ppm),
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while the anomeric proton of the other α-rhamnose showed correlation to C-6 of the β-galactose
(δC 65.9 ppm). Methyl residues of α-rhamnopyranosyl residues were located in the low-field region
of 1H spectrum at δH 0.89 ppm, (3H, d, J = 6.25 Hz) for the α-rhamnosyl residue attached to C-2
of the β-galactose and at δH 1.16 ppm (3H, d, J = 6.08 Hz) for the α-rhamnosyl residue attached to
C-6 of the β-galactose, respectively. Hence, we identified compound 3 as the new natural product
isorhamnetin-3-O-(2,6-di-O-α-rhamnopyranosyl-β-D-galactopyranoside)-7-O-β-D-glucopyranoside.
The compound is similar to compound 7; the difference lies in the absence of β-D-glucopyranosyl
moiety at 7-O position in compound 7.
Compound 4 was isolated as a yellow amorphous powder. Chromatographic analysis showed
Rt 5.40 min. The HR-ESI-MS in negative mode displayed a molecular ion m/z [M − H]− 785.21509
(calcd for [M − H]− 785.21403), confirming molecular formula C34H42O21 with calculated molecular
mass 786.68468 Da. HRESIMS in negative mode showed additional adduct formation m/z [M +
HCOO]− 831.22089, and a hexose (m/z 162.05404) loss leading to m/z 623.16174 (representing cleavage
of glucose from 7-O position or a galactose from 3-O). The moderate fragmentation in positive
ESI (20 eV) showed the presence of m/z 787.2284 for parental ion, and then the corresponding
fragment with a cleavage of deoxyhexose m/z 641.1714, hexose m/z 625.1753, two sugar (rhamnosyl
and hexosyl) units m/z 479.1178 and an aglycone at m/z 317.0658, possible isorhamnetin. After the
interpretation of NMR spectra (Tables 2 and 3), we confirmed the presence of isorhamnetin and
three sugar moieties. Compound 4 possesses similar structure as compound 3, with absence of the
α-rhamnopyranosyl moiety connected to C-2 of β-galactosyl residue, and we identified compound 4
as isorhamnetin-3-O-robinobioside-7-O-glucoside, a new flavonoid glycoside.
3. Discussion
As described above, we isolated 7 flavonoid compounds from A. aitosensis extract. Their structures
were elucidated by 1D (1H, 13C) and 2D NMR experiments (COSY, HSQC, HMBC, NOESY and TOCSY)
and confirmed by HR-ESI-MS. We report the structures of six isorhamnetin and one kaempferol
glycosides (1−7), including three new tetra- (1–3), one new tri-glycoside (4) and three already known
compounds with two (5), three (6) and four (7) sugar units, respectively.
Genus Astragalus is one of the largest genera of Fabaceae family. As mentioned, bioactivity of
Astragalus plants are connected with a presence of flavonoids, saponins and polysaccharides. The use
of Astragalus spp. is mainly connected with immunomodulation, antibacterial and antiviral activity,
and hepatoprotection [9,10]. The reviews of Gorai et al. [16], Bratkov et al. [10], and Li et al. [17] show
an overview of Astragalus genera and flavonoids isolated, showing the presence of flavones, flavonols,
flavanones, flavan-4-ols, isoflavones, isoflavans, pterocarpans and others in 60 different Astragalus
species. Their reviews also include isorhamnetin and kaempferol glycosides. Another comprehensive
review of Bulgarian Astragalus species, published in 2016 [18], similarly describes the presence of
several kaempferol and isorhamnetin glycosides, including alangiflavoside from A. monspessulanus
ssp. monspessulanus [18,19].
In recent years, Bulgarian researchers isolated and reported new tri- and tetraglycosides of
flavonols, including some new compounds from the rarely-met group of flavo-alkaloids [10,11]. Many
species of Astragalus possess in nature the widely-distributed aglycones—kaempferol, quercetin and
methylquercetines—in their free and glycosidic forms [10]. A. aitosensis has previously shown presence
of rutin, quercetin-3-O-β-D-glucoside and astragalin [7]. As visible from comparison of glycosides
isolated from A. aitosensis with the literature, similar compounds—glycosides—were obtained for
example from A. monspessulanus ssp. monspessulanus, A. cicer and A. centralpinus [18–20]. This may,
from chemotaxonomic point of view, confirm their close relationships.
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4. Materials and Methods
4.1. General Experimental Procedures
Optical rotations were measured on a JASCO P-2000 spectropolarimeter (Easton, MD, USA) at
20 ◦C in MeOH with Spectramanager software.
HPLC used configuration of analytical system by Agilent 1100 Series (Degasser G1322A,
Quaternary Pump G1311A, Autosampler ALS G1313A, Column Compartment G1316, DAD G1315B,
Loop 20 µL, UV spectrum 200–900 nm) with column Kinetex® PFP 100 A, 250 mm × 4.6 mm I.D., 5 µm
(Phenomenex, CA, USA), and flow rate of 1 mL/min. Semi-preparative HPLC was carried out using
Dionex UltiMate 3000 system (Pump Dionex UltiMate 3000 UPLC+ Focused, Dionex UltiMate 3000
RS Variable Wavelength Detector, fraction collector Dionex UltiMate 3000 with 6 positions, LCO 101
ECOM column oven, constant temperature 40 ◦C, autosampler Dionex UltiMate 3000, loop 100 µL),
column Ascentis® RP-AMIDE, 250 mm× 10 mm, 5 µm (Supelco, PA, USA), and flow rate of 5 mL/min.
TLC was carried out on precoated silica gel plates (Supelco Kieselgel G, F254, 60, Merck, Darmstadt,
Germany) with the solvent systems EtOAc:MeOH:H2O (100:13.5:10, v/v/v). Spots were visualized
under UV light (365 nm) after spraying with NTS/PEG reagent. Column chromatography (CC) was
performed using Diaion HP-20 (Supelco, PA, USA), Ø = 80 mm, height 70 cm ~ 700 g and Silica gel
(40−63 µm, Sigma-Aldrich®, St. Louis, MO, USA) Ø = 35 mm, height 60 cm.
4.2. Plant Material
The aerial parts of A. aitosensis (Ivan.) Podl (Fabaceae) (syn. Astracantha aitosensis (Ivan.) Podl.)
was collected and identified by Hristo Vasilev in June 2015 in the suburbs of town Aytos, Bulgaria
(coordinates Google maps: 42.702191 N, 27.266976 E, UTM: NH22), voucher specimen has been
deposited in Herbarium of the Institute of Biodiversity and Ecosystem Research, Bulgarian Academy
of Sciences with Ref No. SOM001362.
4.3. Extraction and Isolation
Dried aerial parts (3600 g) of A. aitosensis were extracted under reflux with 80% MeOH (20 ×
1.25 L, 40 min each) at 70 ◦C. The total methanol extract was evaporated to dryness (128 g, 3.5%), and
it was re-suspended in H2O (800 mL) to remove nonpolar compounds by liquid–liquid extraction with
chloroform (200 mL × 5), giving 18 g of CHCl3 fraction and 110 g of MeOH soluble material. This
defatted methanol portion was subjected to Diaion HP-20 column, and eluted with gradient system of
H2O and MeOH (100:0 to 0:100, v/v), giving 10 combined fractions assigned A–J. Fraction B, C, E, and
F were further purified via open column chromatography (Silica gel, eluted with CHCl3:MeOH:H2O
6:4:0.2, v/v/v). Fraction B was re-chromatographed on silica gel (CHCl3:MeOH:H2O 6:4:0.2, v/v/v,
as mobile phase,) and resulted in 6 combined fractions (B1–B6). Fraction B4 was further purified
using a semipreparative HPLC (gradient of acetonitrile in 0.2% HCOOH from 12 to 20% in 25th
minute), and this purification gave compound 4 (27 mg). Fraction B5, after semipreparative HPLC
(gradient of acetonitrile in 0.2% HCOOH from 15% to 18% in 20th minute), gave compound 1 (11
mg). Fraction B6 was purified on semi-preparative HPLC (gradient of acetonitrile in 0.2% HCOOH
from 15% to 20% in 20th minute), gave compounds 7 (20 mg) and 3 (45 mg), respectively. Fraction
C was re-chromatographed on silica gel (mobile phase 6:4:0.2 CHCl3:MeOH:H2O, v/v/v) and this
separation resulted in 45 fractions. Pure compound 2 (24 mg) precipitated from fraction C34. Three
hundred milligrams of fraction E were purified with semipreparative HPLC (gradient of acetonitrile
in 0.2% HCOOH from 19 to 22% in 18th minute), and gave compound 6 (56 mg). Fraction F was
re-chromatographed on silica gel (mobile phase 6:4:0.2 CHCl3:MeOH:H2O, v/v/v), which resulted in
35 fractions, 100 mL each. Pure compound 5 (40 mg) yielded from fraction F10 after re-crystallization
in MeOH.
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4.4. Identification of Isolated Compounds
NMR spectra were recorded on a NMR Agilent DD2 600 MHz (compounds 1–7) and a NMR
Agilent VNMRS 500 MHz (compound 2)—equipped with four and three channels, respectively, and
structure elucidation was carried out using modern 1D and 2D pulse sequences, following 1D and
2D experiments were carried out: 1H, 13C, COSY, HMBC, HSQC, TOCSY, and NOESY. The spectra
were processed with MestReNova version 12.0.0 (Mestrelab Research, Santiago de Compostela, Spain).
Mass spectra were recorded using a Thermo Scientific Q Exactive Plus quadrupole—Orbitrap mass
spectrometer coupled with a UPLC Dionex Ultimate 3000 RSLC system equipped with an RP-18
Kinetex column (2.10 mm × 100 mm, 2.6 µm, Phenomenex Corporation, Torrence, CA, USA). Full-scan
data were recorded in negative ESI mode from m/z 100 to 1500 at a resolution of 70,000 (at m/z 200).
Full-scan dd-MS2 (Top 5) was performed at a resolution of 17 500 (at m/z 200), AGC target 1e5 with
maximum IT 30 ms. For HR-MS in positive mode, Q-TOF mass spectrometer with ultra-high resolution
and high mass accuracy (HRAM) Impact II (Bruker Daltonik, Bremen, Germany) were used. UHPLC
Dionex UltiMate 3000 (Thermo Fisher Scientific, Waltham, MA, USA) was used for LC, with mobile
phases: 0.1% formic acid (A) and MeOH (B), flow rate: 0.2 mL/min, gradient elution: 0 min 5% of B,
3.6 min 10% of B, 10th min 100% of B. Column block temperature was 35 ◦C, and injection volume
5 µL. Kinetex P5, 100A, 1.7um, 100 × 2.1 mm (Phenomenex, Torrance, CA, USA) was used as column.
Solution of natrium formate clusters was used as calibration mixture for accurate mass calibration,
with MS source settings: end plate offset: 500 V, capillary 4500 V, nebulizer pressure 0.3 Bar, dry gas:
4.0 L/min, dry temperature: 250 ◦C. MS/MS spectra were collected at three collision energy levels
of 20, 40, and 60 eV per each peak. Data acquisition were carried out by Control 4.0 and HyStar 3.2
software and the results were processed using Compass DataAnalysis 4.3 (all SW of Bruker Daltonik,
Bremen, Germany). Chromatography was controlled by Chromeleon Xpress link (Thermo Fisher
Scientific, Waltham, MA, USA). For fragmentation analysis Mass Frontier 7.0.5.9 SR3 (High Chem
Ltd., Bratislava, Slovakia) and Thermo Excalibur 3.0.63 (Thermo Fisher Scientific, Waltham, MA, USA)
software was used.
Supplementary Materials: The following are available online. Figures S1–S77: NMR spectra of compounds 1–7,
HRMS of compounds 1–7, and HPLC chromatograms of compounds 1–7.
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